| X | ||||||||||
| 
- Definition The number of targets for co-development by the entity and counterparty under the agreement. No definition available. 
 | 
| X | ||||||||||
| 
- Definition The number of targets independent to counterparty. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Represents the potential payment that may be received upon achievement of specified milestones per agreement. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Amount of research funding the entity is entitled to receive per year on a per collaboration target basis. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Amount of the transaction price of the agreement at inception. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Amount of up-front payment received under terms of the agreement. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available. 
 | 
| X | ||||||||||
| 
- Definition Amount of transaction price allocated to performance obligation that has not been recognized as revenue. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 | 
| X | ||||||||||
| 
- Details 
 |